Abstract
In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Bacterial / blood*
-
Antineoplastic Agents / administration & dosage*
-
Community-Acquired Infections / immunology*
-
Dexamethasone / administration & dosage*
-
Double-Blind Method
-
Female
-
Humans
-
Male
-
Middle Aged
-
Placebos / administration & dosage
-
Pneumonia, Pneumococcal / immunology*
Substances
-
Antibodies, Bacterial
-
Antineoplastic Agents
-
Placebos
-
Dexamethasone